| |
| |
|
| Insider
Information: |
Mcgaughy R Kent Jr |
| Relationship: |
10% Owner |
| City: |
Dallas |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
4,895,473 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$41,977,210 |
|
|
| Total
Shares |
4,895,473 |
|
|
| Total
Value |
$41,977,210 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 125.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Reata Pharmaceuticals Inc |
RETA |
|
2023-09-26 |
0 |
2023-09-26 |
0 |
Premium* |
|
|
Apollo Endosurgery, Inc |
APEN |
|
2016-12-29 |
0 |
2022-12-28 |
4,197,721 |
Premium* |
|
|
Procept Biorobotics Corp |
PRCT |
10% Owner |
|
0 |
2021-09-14 |
697,752 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2023-09-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,901,772) |
0 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(25,004) |
0 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2023-03-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
33,217 |
0 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
|
• • • |
2022-12-28 |
4 |
OE |
$3.25 |
$7,145,629 |
I/I |
2,198,655 |
3,687,781 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
|
• • • |
2021-10-15 |
4 |
B |
$7.75 |
$5,300,000 |
I/I |
683,871 |
2,151,209 |
0.01 |
% |
|
| PRCT |
Procept Biorobotics Corp |
10% Owner |
– – • |
2021-09-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
697,752 |
|
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2020-12-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(166,666) |
2,896,901 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
|
• • • |
2020-07-17 |
4 |
B |
$1.25 |
$2,225,000 |
I/I |
1,780,000 |
1,707,208 |
0.01 |
% |
|
| APEN |
Apollo Endosurgery, Inc |
|
• • • |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
I/I |
57,163 |
507,208 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2019-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
30,478 |
33,217 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2019-11-18 |
4 |
B |
$183.00 |
$7,359,894 |
I/I |
40,218 |
3,063,567 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2018-12-12 |
4 |
B |
$59.90 |
$84,931 |
I/I |
1,418 |
3,023,349 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2018-12-11 |
4 |
B |
$60.07 |
$3,172,337 |
I/I |
52,809 |
3,021,931 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2018-12-10 |
4 |
B |
$57.93 |
$3,326,566 |
I/I |
56,599 |
2,969,122 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-12-29 |
4 |
B |
$28.47 |
$484,016 |
I/I |
17,000 |
2,912,523 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-12-28 |
4 |
B |
$26.10 |
$5,220 |
I/I |
200 |
2,895,523 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-12-27 |
4 |
B |
$25.83 |
$387,444 |
I/I |
15,000 |
2,895,323 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-12-26 |
4 |
B |
$26.06 |
$312,726 |
I/I |
12,000 |
2,880,323 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-12-14 |
4 |
B |
$24.65 |
$1,929,698 |
I/I |
78,275 |
2,868,323 |
0.01 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-12-13 |
4 |
B |
$23.98 |
$3,028,708 |
I/I |
121,725 |
2,790,048 |
0.01 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2017-07-25 |
4 |
B |
$5.50 |
$2,499,998 |
I/I |
454,545 |
469,100 |
2.1 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2017-06-22 |
4 |
A |
$0.00 |
$0 |
I/I |
742,289 |
2,668,323 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2016-12-30 |
4 |
B |
$21.72 |
$204,038 |
I/I |
9,392 |
1,926,034 |
2.64 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
Director |
– • – |
2016-12-29 |
4 |
A |
$0.00 |
$0 |
I/I |
817,804 |
195,330 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
|
• • • |
2016-12-16 |
4 |
B |
$22.99 |
$3,787,820 |
I/I |
164,753 |
1,916,642 |
2.64 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
